Osseodensification Versus Conventional Drilling Effect on Implant Stability

April 20, 2023 updated by: Mahmoud Abu-Ta'a, Arab American University (Palestine)

The Impact of Osseodensification and Conventional Drilling Protocols on Implants Mechanical and Biological Stability in Posterior Maxilla: A Randomized Controlled Clinical Trial

A total of 80 implants were placed in the posterior region of the maxilla in 40 patients in a split-mouth design. Bone quality was classified into type I, II, III, IV, or V as assessed preoperatively on cone-beam computed tomography (CBCT) . Primary implant stability was measured with insertion torque and resonance frequency analysis (ISQ values). Secondary stability was measured by ISQ at abutment installation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • (a) Bilateral edentulism in the maxillary posterior region dating back more than 6 months,
  • (b) sufficient bone height (distance between the bone crest and maxillary sinus >8 mm) and width at the alveolar crest (≥6 mm) that would not necessitate bone augmentation,
  • (c) at least 2 mm vestibular keratinized mucosa width and 3 mm mucosa thickness,
  • (d) full-mouth plaque and bleeding scores <20%.

Exclusion Criteria:

  • patients with systemic diseases, conditions, or used medications having the potential to impair surgery, bone, and wound healing dynamics (such as diabetes) will be excluded.
  • patients who are allergic to antibiotics and non-steroidal anti-inflammatory drugs
  • bone height <8mm
  • ridge and soft tissue deficiencies requiring augmentation procedures and
  • endodontic or periodontal lesions neighboring the edentulous sites will be also excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Osseodensification (test) group
installation of 40 implants using the osseodensification protocol + measurement of implant stability (ISQ)
Implant mechanical and biological stability measured using ISQ values at the time of implant placement and at abutment connection for 40 implants placed in the posterior maxillary area using the osseodensification protocol.
Active Comparator: Conventional (control) group
installation of 40 implants using the conventional drilling protocol + measurement of implant stability (ISQ)
Implant mechanical and biological stability measured using ISQ values at the time of implant placement and at abutment connection for 40 implants placed in the posterior maxillary area using the conventional drilling protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mechanical or primary stability
Time Frame: directly after implant placement
ISQ values at implant installation
directly after implant placement
Biological or secondary stability
Time Frame: 4 months after implant installation
ISQ values at abutment connection
4 months after implant installation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Torque value (N/cm)
Time Frame: directly after implant insertion
Torque value shown at the physiodispenser screen at the end of implant installation
directly after implant insertion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 4, 2022

Primary Completion (Actual)

June 1, 2022

Study Completion (Actual)

February 1, 2023

Study Registration Dates

First Submitted

April 10, 2023

First Submitted That Met QC Criteria

April 20, 2023

First Posted (Actual)

April 24, 2023

Study Record Updates

Last Update Posted (Actual)

April 24, 2023

Last Update Submitted That Met QC Criteria

April 20, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Implant stability

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implant Therapy

Clinical Trials on osseodensification drilling

Subscribe